PTK2 and carcinoma: Regrouping of the seven histotypes into three groups: cystadenoma, borderline cystadenoma and carcinoma, according to their outcomes, revealed that patients with carcinoma expressed significantly more CD41, BCAR1, LOX, FAK, VEGF and MVD compared with the borderline or cystadenoma groups (Fig. 3A–F).